EWM
DNA icon

Evolution Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Evolution Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79 Hold
8
– – ﹤0.01% 932
2026
Q1 		$49 Hold
8
– – ﹤0.01% 848
2025
Q4 		$66 Hold
8
– – ﹤0.01% 742
2025
Q3 		$117 Hold
8
– – ﹤0.01% 584
2025
Q2 		$90 Buy
+8
New +$62 ﹤0.01% 572

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Evolution Wealth Management's DNA Position: Q2 2026 in Review

Evolution Wealth Management held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 8 shares worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Evolution Wealth Management first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $117 in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Evolution Wealth Management held 8 shares of Ginkgo Bioworks worth $79 as of Q2 2026.
  • Evolution Wealth Management left its Ginkgo Bioworks share count unchanged in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Evolution Wealth Management's portfolio in Q2 2026, its #932 holding.
  • Evolution Wealth Management first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • Evolution Wealth Management's Ginkgo Bioworks position peaked at $117 in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.